A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents

NCT02716233 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

2044

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: pegaspargase 1250 IU/m2 x 2
DRUG: pegaspargase 2500 IU/m2 x 1

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]